医学分子生物学杂志 ›› 2026, Vol. 23 ›› Issue (4): 406-411.doi: 10.3870/j.issn.1672-8009.2026.04.005

• 论著 • 上一篇    下一篇

miR-429通过Wnt/β-catenin通路影响慢性难愈合创面修复

黄文文1, 孟丽2, 谢辉1, 胡寿勇1, 石华峰1   

  1. 荆门市中心医院/荆楚理工学院附属荆门市中心医院1创伤骨科,2内分泌科 湖北省荆门市,448001
  • 收稿日期:2025-12-09 发布日期:2026-09-28
  • 通讯作者: 黄文文(E-mail:hwwen15327536882@163.com)
  • 基金资助:
    荆门市科学技术局项目(No.2022YFZD218)

miR-429 Affects Chronic Non-Healing Wound Repair through Wnt/β-catenin Pathway

HUANG Wenwen1, MENG Li2, XIE Hui1, HU Shouyong1, SHI Huafeng1   

  1. 1Department of Trauma and Orthopedics,2Department of Endocrinology,Jingmen Central Hospital/Jingmen Central Hospita Affiliated to Jingchu University of Technology,Jingmen,Hubei,448001,China
  • Received:2025-12-09 Published:2026-09-28
  • Contact: HUANG Wenwen(E-mail:hwwen15327536882@163.com)
  • Supported by:
    Jingmen Municipal Bureau of Science and Technology (No. 2022YFZD218)

摘要: 目的 探究miR-429对慢性难愈合创面修复及Wnt/β-catenin信号通路的影响。方法 将60大鼠随机分为空白对照组、模型组、阴性对照组(注射antagomir NC)、LV-429组(注射miR-429 antagomir慢病毒)和抑制剂组(注射miR-429 antagomir慢病毒+Wnt/β-catenin信号通路抑制剂IWP-2)。统计大鼠创面愈合率,取创面组织检测miR-429水平,Wnt3a和β-catenin蛋白表达量,血管内皮生长因子A(vascular endothelial growth factor A,VEGFA),内皮型一氧化氮合酶(endothelial nitric oxide synthase,ENOS)表达情况。取大鼠血清检测白介素6(interleukin-6,IL-6)和肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)水平。结果 与模型组和阴性对照组比较,LV-429组和抑制剂组miR-429表达下降。与模型组和阴性对照组比较,LV-429组换药第3、6、12天时创面愈合率,Wnt3a、β-catenin的蛋白表达,VEGFA、ENOS阳性表达率均上升,IL-6和TNF-α水平均下降(P<0.05),抑制剂组创面愈合率,Wnt3a、β-catenin的蛋白表达,VEGFA、ENOS阳性表达率均下降,IL-6和TNF-α水平均上升(P<0.05)。结论 抑制miR-429的表达可促进慢性难愈合创面修复,该过程通过激活Wnt/β-catenin信号通路介导。

关键词: miR-429, 创面修复, Wnt/β-catenin通路

Abstract: Objective To investigate the effects of miR-429 on the healing of chronic non-healing wounds and the Wnt/β-catenin signaling pathway. Methods A total of 60 rats were randomly divided into 5 groups:blank control group,model group,negative control group(injected with antagomir NC),LV-429 group(injected with miR-429 antagomir lentivirus),and inhibitor group(injected with miR-429 antagomir lentivirus and Wnt/β-catenin signaling pathway inhibitor IWP-2).The wound healing rates in rats were assessed,and wound tissue samples were collected for measurement of miR-429 levels,as well as the protein expression of Wnt3a and β-catenin,and the expression of vascular endothelial growth factor A(VEGFA)and endothelial nitric oxide synthase(ENOS).Rat serum samples were collectedor measurement of the levels of interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α). Results Compared with that in the model group and the negative control group,the miR-429 expression level was reduced in the LV-429 group and the inhibitor group.Compared with the model group and the negative control group,in the LV-429 group,the wound healing rates,Wnt3a,β-catenin protein expression,and the positive expression rates of VEGFA and ENOS were all increased,while the IL-6 and TNF-α levels were both decreased(P<0.05).In the inhibitor group,the wound healing rate,Wnt3a and β-catenin protein expression,and the positive expression rates of VEGFA and ENOS were all decreased,while the IL-6 and TNF-α levels were both increased(P<0.05). Conclusion Inhibiting the expression of miR-429 can promote the repair of chronic refractory wounds,and this process is mediated by activating the Wnt/β-catenin signaling pathway.

Key words: miR-429, wound repair, Wnt/β-catenin signaling pathway, vascular endothelial growth factor A, endothelial nitric oxide synthase, wound healing rate, interleukin-6, tumor necrosis factor-α

中图分类号: